This inventor holds 3 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Rigel Pharmaceuticals, Incorporated, Genomic Health, Inc.. Active years: 2007-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Foster City, CA (US) (2007)
- Palo Alto, CA (US) (2011 - 2019)
Company Filing History:
Years Active: 2007-2019
Title: The Innovative Contributions of Kunbin Qu
Introduction
Kunbin Qu is a prominent inventor based in Palo Alto, California, renowned for his significant contributions to the field of biotechnology. With a remarkable portfolio of three patents, his work focuses on advancing our understanding of genetic factors related to diseases such as breast cancer. His innovative research has implications for both diagnosis and treatment, making him a key figure in his area of expertise.
Latest Patents
Among Kunbin Qu's latest patents is a groundbreaking invention titled "Gene fusions and alternatively spliced junctions associated with breast cancer." This patent details novel methods for identifying gene fusions and alternative spliced junctions within RNA sequencing data, significantly enhancing prognosis predictions for breast cancer patients based on gene fusion events.
Another notable patent he holds is "Identification of pharmacophores from co-crystals of spleen tyrosine kinase (SYK) and SYK ligands." This invention encompasses methods for identifying pharmacophores centered on the SYK protein and its fragments. It also provides approaches to discover SYK inhibitors using pharmacophores identified from co-crystals of SYK and its ligands, offering new avenues for cancer treatment.
Career Highlights
Throughout his career, Kunbin Qu has gained valuable experience working with leading healthcare companies, including Rigel Pharmaceuticals and Genomic Health. His roles at these institutions have undoubtedly influenced his innovative thinking and ability to address pressing medical challenges.
Collaborations
Kunbin Qu has collaborated with several talented individuals, including colleagues Nan Lin and Yanmei Lu. Their joint efforts have contributed to the success of his research initiatives and the advancement of patent applications in the biotechnology sector.
Conclusion
In summary, Kunbin Qu stands out as an influential inventor in the biotechnology field, with a focused commitment to addressing complex medical issues through his innovative solutions. His patented inventions not only enhance our understanding of breast cancer but also pave the way for potential therapeutic strategies, ensuring his lasting impact on health and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile